Companies / Eisbach Bio
Eisbach Bio
Planegg, Germany
Eisbach Bio is a clinical-stage biotechnology company developing next-generation small-molecule cancer therapies by targeting the activated state of enzymes.
Eisbach Bio, based in Planegg, Germany, has 1 investor on file, among them Cancer Focus Fund. Its site was last checked 7 Nov 2026: site answers.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from Cancer Focus Fund
6 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%).
See Cancer Focus Fund's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Eisbach Bio and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Cancer Focus Fund adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/eisbach.bio/investors
# also
GET /v1/companies/eisbach.bio
GET /v1/companies/eisbach.bio/news